(CD52, CCL5, and IL32), and was resemble with a group of dysfunctional CD8 T cells recently identified in melanoma, esophageal squamous cell cancer and liver cancer (21–23). This evidence concerns the gene CD52 and esophageal squamous cell carcinoma.